tiprankstipranks
Linc AB (SE:LINC)
:LINC
Want to see SE:LINC full AI Analyst Report?

Linc AB (LINC) Price & Analysis

0 Followers

LINC Stock Chart & Stats

kr69.40
-kr0.60(-0.89%)
At close: 4:00 PM EST
kr69.40
-kr0.60(-0.89%)

Bulls Say, Bears Say

Bulls Say
Debt-free Balance SheetA zero-debt balance sheet materially lowers financing and solvency risk over the next 2-6 months, giving management flexibility to fund follow-on investments or weather portfolio drawdowns without urgent external financing, supporting durable capital allocation optionality.
Life-science Focused Investment ModelA concentrated, sector-focused active ownership model provides durable competitive advantages: specialized sourcing, operational guidance, and exit know-how in life sciences. This increases odds of value creation from portfolio development and strategic exits over medium term horizons.
Reported Revenue GrowthA reported ~21% revenue growth metric suggests recent expansion in underlying activities or portfolio-derived revenues. Sustained top-line growth over months improves the base for recurring distributions or higher valuation on exits, improving medium-term realization prospects.
Bears Say
Weak Cash GenerationNegative operating and free cash flow over the TTM period reduces internal funding available for follow-on investments, dividends, or deal support. Over 2-6 months this limits financial flexibility and may force asset sales or external funding at inopportune times.
Uneven Earnings QualityProfitability driven by non-operating gains and volatile revenue undermines predictability of recurring earnings. Reliance on valuation-driven results makes sustainable profit generation uncertain and complicates planning for distributions or reinvestment over the medium term.
Declining Equity And Volatile ROEA shrinking equity base and swings in ROE indicate inconsistent value creation and reduced capital buffer. Persisting downward equity trends can weaken resilience to losses and limit capacity to support portfolio companies without dilutive or costly capital raises.

LINC FAQ

What was Linc AB’s price range in the past 12 months?
Linc AB lowest stock price was kr58.90 and its highest was kr83.60 in the past 12 months.
    What is Linc AB’s market cap?
    Linc AB’s market cap is kr4.23B.
      When is Linc AB’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Linc AB’s earnings last quarter?
      Currently, no data Available
      Is Linc AB overvalued?
      According to Wall Street analysts Linc AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Linc AB pay dividends?
        Linc AB does not currently pay dividends.
        What is Linc AB’s EPS estimate?
        Linc AB’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Linc AB have?
        Linc AB has 57,910,446 shares outstanding.
          What happened to Linc AB’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Linc AB?
          Currently, no hedge funds are holding shares in SE:LINC
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Linc AB

            Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.

            Linc AB (LINC) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Creades AB
            Idun Industrier AB Class B
            Vo2 Cap Holding AB
            Svolder AB Class B
            MedCap AB

            Options Prices

            Currently, No data available
            ---
            Popular Stocks